Patients’ preferences and willingness-to-pay for postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer treatments after failure of standard treatments
Surachat Ngorsuraches
◽
Klangjai Thongkeaw
2012 ◽
Vol 15
(7)
◽
pp. A419
F. Andre
◽
N. Marinsek
◽
J.F. Ricci
◽
J. Etchberger
◽
R. Degun
◽
...
2013 ◽
Vol 8
(4)
◽
pp. 293-299
◽
Michael Gnant
◽
Richard Greil
◽
Michael Hubalek
◽
Günther Steger
2017 ◽
Vol 18
(7)
◽
pp. 904-916
◽
José Baselga
◽
Seock-Ah Im
◽
Hiroji Iwata
◽
Javier Cortés
◽
Michele De Laurentiis
◽
...
2012 ◽
Vol 366
(6)
◽
pp. 520-529
◽
José Baselga
◽
Mario Campone
◽
Martine Piccart
◽
Howard A. Burris
◽
Hope S. Rugo
◽
...
2013 ◽
Vol 24
(1)
◽
pp. 79-81
S.A. Hurvitz
◽
P.F. Peddi
2019 ◽
Vol 10
(4)
◽
pp. e69-e73
Jean-Lionel Bagot
◽
Ingrid Theunissen
◽
Jean-Claude Karp
◽
Jean-Philippe Wagner
Alex Toker
◽
Kristin Brown
2012 ◽
Vol 2012
◽
pp. 74-75
Close
Export Citation Format
Close
Share Document
Close